From Casetext: Smarter Legal Research

In re Yasmin

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION
Oct 20, 2011
MDL No. 2100 (N.D. Cal. Oct. 20, 2011)

Opinion

MDL No. 2100

10-20-2011

In re: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION


(SEE ATTACHED SCHEDULE)


CONDITIONAL TRANSFER ORDER (CTO-80)

On October 1, 2009, the Panel transferred 32 civil action(s) to the United States District Court for the Southern District of Illinois for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. §1407. See 655 F.Supp.2d 1343 (J.P.M.L. 2009). Since that time, 834 additional action(s) have been transferred to the Southern District of Illinois. With the consent of that court, all such actions have been assigned to the Honorable David R Herndon. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Illinois and assigned to Judge Hemdon. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. §1407 to the Southern District of Illinois for the reasons stated in the order of October 1, 2009, and, with the consent of that court, assigned to the Honorable David R Herndon. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Southern District of Illinois. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Jeffery N. Lüthi

Clerk of the Panel

SCHEDULE CTO-80 -- TAG-ALONG ACTIONS

+-----------------------------------------------------------------------------+ ¦ DIST ¦ DIV. ¦ C.A.NO. ¦ CASE CAPTION ¦ +-----------------------------------------------------------------------------¦ ¦CALIFORNIA NORTHERN ¦ +-----------------------------------------------------------------------------¦ ¦CAN ¦3 ¦11-04946 ¦Middleton v. Bayer Corp. et al ¦ +-----------------------------------------------------------------------------¦ ¦MINNESOTA ¦ +-----------------------------------------------------------------------------¦ ¦ ¦ ¦ ¦Takashima et al v. Bayer Healthcare Pharmaceuticals, ¦ ¦MN ¦0 ¦11-02917 ¦ ¦ ¦ ¦ ¦ ¦Inc.et al ¦ +-----------------------------------------------------------------------------¦ ¦NEW YORK EASTERN ¦ +-----------------------------------------------------------------------------¦ ¦ ¦ ¦ ¦Pozarycki v. Bayer Healthcare Pharmaceuticals, Inc. ¦ ¦NYE ¦1 ¦11-03298 ¦et ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦ ¦al ¦ +------+------+---------+-----------------------------------------------------¦ ¦NYE ¦1 ¦11-04803 ¦Cruz v. Bayer Corporation et al ¦ +-----------------------------------------------------------------------------+


Summaries of

In re Yasmin

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION
Oct 20, 2011
MDL No. 2100 (N.D. Cal. Oct. 20, 2011)
Case details for

In re Yasmin

Case Details

Full title:In re: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND…

Court:UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION

Date published: Oct 20, 2011

Citations

MDL No. 2100 (N.D. Cal. Oct. 20, 2011)